Super piggyBac—Engineered for Performance
Hera BioLabs is the exclusive licensed provider of the patented Super piggyBac system for drug discovery research, diagnostics, synthetic biotechnology and agricultural applications. When performance matters—and freedom to operate is essential—partner with the team that brings over a decade of experience and validated protocols.
How piggyBac Works
Step 1: Clone cargo into transposon vector
Step 2: Co-transfect Transposon and Transposase into cells.
Step 3: Transposase cuts out cargo and pastes into random TTAA sites.
Step 4: Screen clones for desired insert.
Step 5: Use Excision-only piggyBac for Footprint-Free gene editing. (optional)
Super piggyBac is a next-generation protein engineered transposase that outperforms other technologies in stable gene integration and expression, cargo size, and seamless excision. Developed through protein engineering and protected by both patents and trademarks, Hera has also developed a unique manufacturing process that results in even higher activity with its optimized mRNA Super piggyBac transposase.
Features of super piggyBac
- Stable integrating of genetic cargo ranging from small to exceptionally large sizes (200kb or more)
- Superior transposase efficiency across diverse cell lines and species
- Integration into open chromatin regions ensures stable and high-level gene expression.
- No excision scars
- IP license rights—only from Hera
Super piggyBac is Validated for Commercial Research and Product Development In:
Screening Cell Lines
Potency Assays
Synthetic Biotechnology
In Vivo Models
Agriculture And Beyond
The Industry Standards for Stable
Gene Insertion and Expression
piggyBac has been featured in 800+ papers including the high-impact publications below.
See how Hera’s technology and staff are assisting researchers globally in solving complex problems and producing robust data.
Shop Gene Editing Reagents
Super piggyBac Starter Kit
Designed for first-time super piggyBac evaluations
| CATALOG # | DESCRIPTION | AMOUNT | ORDER |
|---|---|---|---|
| R03 D02 D01 D04 |
Test super piggyBac transposase in mRNA (SPB-100) and plasmid DNA (SPB-D25) formats, alongside transposons with piggyBac ITRs, core insulators, and MCS for cargo insertion (SPB-007) or MCS with GFP and Puro selection (SPB-012).
|
Transposases 25 µg Transposons 10 µg |
Contact Us |
Super piggyBac Products
| CATALOG # | DESCRIPTION | AMOUNT | ORDER |
|---|---|---|---|
| R03 |
Super piggyBac transposase mRNA
|
25 µg | Contact Us |
| D02 |
Super piggyBac transposase DNA
|
25 µg | Contact Us |
| D03 |
Excision-only super piggyBac transposase DNA
|
25 µg | Contact Us |
| D01 |
Empty piggyBac transposon base vector with multiple cloning site (MSC)
|
10 µg | Contact Us |
| D04 |
piggyBac transposon containing a CMV promoter-MCS-SV40PolyA for cloning gene of interest and a GFP-Puro selection cassette.
|
10 µg | Contact Us |
All reagents are provided at a 1 ug/ul concentration per vial. Shipping for RNA reagents will be on dry ice. Shipping for DNA reagents will be ambient temperature or on ice. Transposases are designed for direct use and cannot be propagated.
Why Licensing Matters
Super piggyBac® is not open-source. It is protected by U.S. and international patents and is a registered trademark. Hera BioLabs, a Demeetra company, is the sole licensed provider of Super piggyBac for research, drug discovery, synthetic biotechnology and other applications. Partnering with us enables confident internal research and provides a clear path to commercializing your engineered cell and animal models.
Our Latest
Insights From Hera’s Team
Learn from Industry experts with thought leadership content about Hera’s piggyBac technology.
Genetically Immortalized Cells: Unlocking the Potential for Scalable Cultured Meat Production
Genetically Immortalized Cells: Unlocking the Potential for Scalable Cultured [...]
How the piggyBac® Transposon Sheds Light on Breast Cancer Drug Resistance
With over 2.2 million annual cases, breast cancer is the [...]
Advantages of Utilizing the SRG rat for Investigating Tumor Metastasis
The dissemination of tumor cells into systemic circulation is [...]
